EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Harnessing the Power of Metabolomics for Precision Oncology: Current Advances and Future Directions

Manas Kohli iD, George Poulogiannis iD

Cells · 2025

DOI: 10.3390/cells14060402 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2025. Verfasst von Manas Kohli und 1 weiteren Autor:innen. Beteiligte Einrichtung: Signalling and Cancer Metabolism Laboratory, Division of Cell and Molecular Biology, The Institute of Cancer Research, 237 Fulham Road, London SW3 6J…. Hauptthemen laut MEDLINE: Metabolomics, Precision Medicine, Neoplasms, Medical Oncology. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Research and Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic reprogramming is a hallmark of cancer, with cancer cells acquiring many unique metabolic traits to support malignant growth, and extensive intra- and inter-tumour metabolic heterogeneity. Understanding these metabolic characteristics presents opportunities in precision medicine for both diagnosis and therapy. However, despite its potential, metabolic phenotyping has lagged behind genetic, transcriptomic, and immunohistochemical profiling in clinical applications. This is partly due to the lack of a single experimental technique capable of profiling the entire metabolome, necessitating the use of multiple technologies and approaches to capture the full range of cancer metabolic plasticity. This review examines the repertoire of tools available for profiling cancer metabolism, demonstrating their applications in preclinical and clinical settings. It also presents case studies illustrating how metabolomic profiling has been integrated with other omics technologies to gain insights into tumour biology and guide treatment strategies. This information aims to assist researchers in selecting the most effective tools for their studies and highlights the importance of combining different metabolic profiling techniques to comprehensively understand tumour metabolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetabolomicsPrecision MedicineNeoplasmsMedical OncologyHumansMetabolomeAnimals

Stichwörter der Autor:innen

cancermetabolomemetabolomicsprecision medicinetherapy

Autor:innen und Institutionen

  • Signalling and Cancer Metabolism Laboratory, Division of Cell and Molecular Biology, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK.

ORCID-Profile: Manas Kohli, George Poulogiannis

Förderung

  • UK Research and Innovation

Zitieren

APA

Kohli, M., & Poulogiannis, G. (2025). Harnessing the Power of Metabolomics for Precision Oncology: Current Advances and Future Directions. Cells. https://doi.org/10.3390/cells14060402

Vancouver

Kohli M, Poulogiannis G. Harnessing the Power of Metabolomics for Precision Oncology: Current Advances and Future Directions. Cells. 2025. doi:10.3390/cells14060402

BibTeX
@article{Kohli2025,
  author = {Kohli, Manas and Poulogiannis, George},
  title = {Harnessing the Power of Metabolomics for Precision Oncology: Current Advances and Future Directions},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14060402}
}
Kostenlos starten →